基于细胞的免疫疗法中的免疫逃避:解开挑战和新的战略
Yan-Ruide Li1, Tyler Halladay2, Lili Yang3,4,5,6
1Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA. charlie.li@ucla.edu.
Journal of biomedical science
|January 12, 2024
概括
基于细胞的免疫疗法 (CBIs) 在癌症治疗中表现有前途,但瘤通过免疫逃避来发展抵抗力. 这篇评论探讨了瘤抵抗机制和克服它们的策略,以有效的癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 基于细胞的免疫疗法 (CBIs),包括化学抗原受体 (CAR) -T细胞疗法,代表了癌症治疗的重大进展.
- 瘤细胞已经发展出复杂的免疫逃避策略,以抵抗治疗干预.
- 瘤微环境 (TME) 在培养免疫抑制环境方面发挥着关键作用,阻碍了CBI的有效性.
研究的目的:
- 审查瘤细胞逃避基于细胞的免疫疗法 (CBIs) 的内在机制.
- 识别和讨论未来的策略,以克服瘤免疫逃避和提高CBI在癌症治疗中的有效性.
主要方法:
- 本综述综合了与CBI相关的瘤免疫逃避机制的当前文献.
- 对关键途径和参与瘤抗免疫治疗的细胞过程的分析.
主要成果:
- 瘤免疫逃避是由多种机制调解的,包括抗原损失,抗原呈现受损和免疫检查点的激活.
- 其他关键机制包括诱导抗亡信号和促进TME内的免疫细胞功能障碍和疲劳.
- 这些逃避策略共同限制了CBI的治疗效果.
结论:
- 了解瘤抵抗机制对于开发下一代CBIs至关重要.
- 针对这些逃避途径为改善癌症免疫治疗患者的结果提供了有希望的途径.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cytotoxic T Cells-mediated Immune Response
921
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Cell-mediated Immune Responses
68.3K
Overview
68.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


